Make scientific figures in minutes
Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software
Use Icons In The App
Try a synonym, or sign up to request an icon from the app.
Person with Parkinson's (symbol)
[{"image":"https://icons.cdn.biorender.com/w75xh75/64a5bc43a5daea0b25094471/64a5bbf5a5daea861d094454.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64a5bc43a5daea0b25094471/64a5bbf5a5daea861d094454.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64a5bc43a5daea3e80094470/64a5bbf5a5daea861d094454.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64a5bc43a5daea3e80094470/64a5bbf5a5daea861d094454.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64a5bc43a5daeaea0209446f/64a5bbf5a5daea861d094454.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64a5bc43a5daeaea0209446f/64a5bbf5a5daea861d094454.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64a5bc43a5daea710909446e/64a5bbf5a5daea861d094454.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64a5bc43a5daea710909446e/64a5bbf5a5daea861d094454.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64a5bc43a5daea9ef709446d/64a5bbf5a5daea861d094454.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64a5bc43a5daea9ef709446d/64a5bbf5a5daea861d094454.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64a5bc43a5daeabf5b09446c/64a5bbf5a5daea861d094454.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64a5bc43a5daeabf5b09446c/64a5bbf5a5daea861d094454.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64a5bc43a5daea179809446b/64a5bbf5a5daea861d094454.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64a5bc43a5daea179809446b/64a5bbf5a5daea861d094454.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64a5bc43a5daeadf8309446a/64a5bbf5a5daea861d094454.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64a5bc43a5daeadf8309446a/64a5bbf5a5daea861d094454.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64a5bc43a5daea6b16094469/64a5bbf5a5daea861d094454.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64a5bc43a5daea6b16094469/64a5bbf5a5daea861d094454.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64a5bc43a5daea782a094468/64a5bbf5a5daea861d094454.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64a5bc43a5daea782a094468/64a5bbf5a5daea861d094454.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64a5bc43a5daea229a094467/64a5bbf5a5daea861d094454.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64a5bc43a5daea229a094467/64a5bbf5a5daea861d094454.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64a5bc43a5daea692a094466/64a5bbf5a5daea861d094454.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64a5bc43a5daea692a094466/64a5bbf5a5daea861d094454.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64a5bc43a5daea4e3b094465/64a5bbf5a5daea861d094454.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64a5bc43a5daea4e3b094465/64a5bbf5a5daea861d094454.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64a5bc43a5daea10cb094464/64a5bbf5a5daea861d094454.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64a5bc43a5daea10cb094464/64a5bbf5a5daea861d094454.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64a5bc43a5daea6633094463/64a5bbf5a5daea861d094454.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64a5bc43a5daea6633094463/64a5bbf5a5daea861d094454.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64a5bc43a5daea3f17094462/64a5bbf5a5daea861d094454.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64a5bc43a5daea3f17094462/64a5bbf5a5daea861d094454.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64a5bc43a5daea31ed094461/64a5bbf5a5daea861d094454.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64a5bc43a5daea31ed094461/64a5bbf5a5daea861d094454.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64a5bc43a5daea97ba094460/64a5bbf5a5daea861d094454.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64a5bc43a5daea97ba094460/64a5bbf5a5daea861d094454.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64a5bc43a5daead8fc09445f/64a5bbf5a5daea861d094454.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64a5bc43a5daead8fc09445f/64a5bbf5a5daea861d094454.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64a5bc43a5daea623209445e/64a5bbf5a5daea861d094454.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64a5bc43a5daea623209445e/64a5bbf5a5daea861d094454.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64a5bc43a5daeac32109445d/64a5bbf5a5daea861d094454.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64a5bc43a5daeac32109445d/64a5bbf5a5daea861d094454.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64a5bc43a5daea5b0709445c/64a5bbf5a5daea861d094454.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64a5bc43a5daea5b0709445c/64a5bbf5a5daea861d094454.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64a5bc43a5daeafa4a09445b/64a5bbf5a5daea861d094454.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64a5bc43a5daeafa4a09445b/64a5bbf5a5daea861d094454.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64a5bc43a5daea0a3709445a/64a5bbf5a5daea861d094454.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64a5bc43a5daea0a3709445a/64a5bbf5a5daea861d094454.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64a5bc43a5daea5b34094459/64a5bbf5a5daea861d094454.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64a5bc43a5daea5b34094459/64a5bbf5a5daea861d094454.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64a5bc43a5daea0263094458/64a5bbf5a5daea861d094454.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64a5bc43a5daea0263094458/64a5bbf5a5daea861d094454.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64a5bc43a5daea61aa094457/64a5bbf5a5daea861d094454.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64a5bc43a5daea61aa094457/64a5bbf5a5daea861d094454.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64a5bc43a5daea481c094456/64a5bbf5a5daea861d094454.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64a5bc43a5daea481c094456/64a5bbf5a5daea861d094454.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/64a5bc43a5daea5e3c094455/64a5bbf5a5daea861d094454.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/64a5bc43a5daea5e3c094455/64a5bbf5a5daea861d094454.png"}]
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes
SIGN UP FREEKeywords
person with parkinson's,parkinson,parkinson's,parkinson's disease,brain disorder,shaking,stiffness,balance,coordination,degeneration,movement,pathology,diseased,disease,sick,sickly,pathological,abnormal,ill,unwell,unhealthy,neurological disorder,person,people,human,person,human figure,silhouette,individual,man,side,lateral,standing,male,female,guy,boy,gentleman,girl,gal,lady,woman,normal,population,cohort,schematic,symbol,symbolic,sign,icon,iconography,mark,signify,simple,proj-icon-gaps-23q2,proj-icon-gaps-23q2-parkinson,proj-icon-gaps-23q2-symbol,person with parkinson's,parkinson,parkinson's,parkinson's disease
Image types
BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More
Join 1,500,000 other scientists on BioRender
Sign up for your free account and start creating scientific figures faster today
FAQs
What is BioRender?
Can I use this icon in a BioRender figure or scientific illustration?
